Related Experiment Video
Updated: Mar 21, 2026

08:25
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
3.6K
Cholinergic urticaria: More than a simple inducible urticaria
1Department of Dermatology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
The Australasian Journal of Dermatology
|May 14, 2016
Summary
Cholinergic urticaria (ChU) can present without visible hives, manifesting as itching or burning. Recognizing these varied symptoms is key for effective ChU management.
Area of Science:
- Dermatology
- Allergology
- Immunology
Background:
- Cholinergic urticaria (ChU) is a condition causing small hives due to increased body temperature.
- The exact causes and clinical presentations of ChU remain unclear.
- This study investigated the diverse symptoms and signs of ChU in a Korean patient cohort.
Purpose of the Study:
- To characterize the full spectrum of clinical manifestations in Korean patients with Cholinergic urticaria.
- To identify demographic patterns and symptom variations in ChU.
- To inform diagnostic and therapeutic approaches for ChU.
Main Methods:
- Retrospective analysis of medical records for patients diagnosed with ChU.
- Data collection included patient demographics, symptom presentation, and treatment response.
Main Results:
- 203 patients diagnosed with ChU were analyzed (188 male, 15 female).
- 14% of patients reported only itching or burning without visible skin lesions.
- ChU prevalence peaked in the twenties, with symptom onset most common in the teens.
- Patients with visible hives responded better to antihistamines than those without.
Conclusions:
- Cholinergic urticaria presents with varied symptoms, including pruritus and erythema without obvious hives.
- Physicians should consider these less common presentations for accurate diagnosis.
- Broader recognition of ChU manifestations can improve patient management and treatment outcomes.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
Cholinergic Receptors: Muscarinic
5.9K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
5.9K
Allergic Reactions
33.4K
Overview
33.4K
Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.5K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.5K
Hypersensitivity Reactions: Immune-Complex Reactions
121
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
121

